← Back to Screener
Baxter International Inc. (BAX)
Price$18.14
Favorite Metrics
Price vs S&P 500 (26W)-23.96%
Price vs S&P 500 (4W)2.54%
Market Capitalization$9.34B
Indicated Dividend Yield (Annual)0.23%
All Metrics
P/CF (Annual)11.06x
Book Value / Share (Quarterly)$11.92
P/TBV (Annual)5.58x
Indicated Dividend (Annual)$0.68
Revenue Growth (3Y)-9.39%
Cash Flow / Share (Quarterly)$0.65
Payout Ratio (TTM)90.20%
Price vs S&P 500 (YTD)-7.97%
Gross Margin (TTM)30.68%
Net Profit Margin (TTM)-8.51%
EPS (TTM)$-1.87
10-Day Avg Trading Volume6.09M
EPS Excl Extra (TTM)$-1.87
Revenue Growth (5Y)-0.75%
EPS (Annual)$-1.87
Dividend / Share (Annual)$0.68
ROI (Annual)-6.13%
Gross Margin (Annual)30.68%
Net Profit Margin (5Y Avg)-0.55%
Cash / Share (Quarterly)$3.82
Revenue Growth QoQ (YoY)8.03%
ROA (Last FY)-4.77%
Revenue Growth TTM (YoY)-12.54%
EBITD / Share (TTM)$0.11
ROE (5Y Avg)-4.18%
Operating Margin (TTM)-2.60%
Cash Flow / Share (Annual)$0.65
P/B Ratio1.52x
P/B Ratio (Quarterly)1.60x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.50x
Net Interest Coverage (TTM)-0.91x
ROA (TTM)-4.59%
EV / EBITDA (TTM)295.64x
EPS Incl Extra (Annual)$-1.87
Current Ratio (Annual)2.31x
Quick Ratio (Quarterly)1.31x
3-Month Avg Trading Volume9.25M
52-Week Price Return-34.75%
EV / Free Cash Flow (Annual)50.76x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.42
P/S Ratio (Annual)0.83x
Asset Turnover (Annual)0.56x
52-Week High$32.68
Operating Margin (5Y Avg)0.22%
EPS Excl Extra (Annual)$-1.87
CapEx CAGR (5Y)-6.27%
Tangible BV CAGR (5Y)-22.78%
26-Week Price Return-19.41%
Quick Ratio (Annual)1.48x
13-Week Price Return-7.68%
Total Debt / Equity (Annual)1.55x
Current Ratio (Quarterly)2.31x
Enterprise Value$16,851.589
Revenue / Share Growth (5Y)-0.59%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)-7.08%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.64x
Pretax Margin (Annual)-4.49%
Cash / Share (Annual)$3.82
3-Month Return Std Dev51.92%
Gross Margin (5Y Avg)34.63%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-31.69%
EBITDA Interim CAGR (5Y)-13.51%
ROE (Last FY)-15.61%
Net Interest Coverage (Annual)-0.91x
EPS Basic Excl Extra (Annual)$-1.87
P/FCF (TTM)14.44x
Receivables Turnover (TTM)6.14x
EV / Free Cash Flow (TTM)50.76x
Total Debt / Equity (Quarterly)1.55x
EPS Incl Extra (TTM)$-1.87
Receivables Turnover (Annual)6.14x
ROI (TTM)-5.77%
Dividend Growth Rate (5Y)-6.21%
P/S Ratio (TTM)0.83x
Pretax Margin (5Y Avg)-1.92%
Revenue / Share (Annual)$21.92
Tangible BV / Share (Annual)$3.42
Forward P/E9.50x
Free OCF CAGR (5Y)-22.12%
Price vs S&P 500 (52W)-65.26%
Year-to-Date Return-5.08%
5-Day Price Return5.77%
EPS Normalized (Annual)$-1.87
ROA (5Y Avg)-0.53%
Net Profit Margin (Annual)-8.51%
Month-to-Date Return7.98%
Cash Flow / Share (TTM)$2.60
EBITD / Share (Annual)$-0.08
Operating Margin (Annual)-2.64%
LT Debt / Equity (Annual)1.54x
P/CF (TTM)11.06x
ROI (5Y Avg)-0.69%
LT Debt / Equity (Quarterly)1.55x
EPS Basic Excl Extra (TTM)$-1.87
P/TBV (Quarterly)5.58x
P/B Ratio (Annual)1.60x
Dividend / Share (TTM)$0.68
Inventory Turnover (TTM)3.64x
Pretax Margin (TTM)-4.49%
Book Value / Share (Annual)$11.92
Price vs S&P 500 (13W)-8.82%
Dividend Yield (TTM)3.73%
Beta0.64x
P/FCF (Annual)28.14x
Revenue / Share (TTM)$21.92
ROE (TTM)-13.78%
52-Week Low$15.73
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.76
2.76
3.23
3.23
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BAXBaxter International Inc. | 0.83x | -0.75% | 30.68% | -2.60% | $18.14 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Baxter supplies medical devices and therapies to hospitals and care settings, including injectable products, IV systems, nutritional solutions, and surgical sealants. The company expanded its hospital equipment portfolio through its 2021 Hillrom acquisition and divested its kidney care business in early 2025.